![Webinar: Manufacturers of COVID-19 Molecular Diagnostic Tests: Qiagen and Thermofisher Scientific – Africa CDC Webinar: Manufacturers of COVID-19 Molecular Diagnostic Tests: Qiagen and Thermofisher Scientific – Africa CDC](https://africacdc.org/wp-content/uploads/2020/04/Manufacturers-COVID-19-Tests-Qiagen-Thermofisher-Scientific.jpg)
Webinar: Manufacturers of COVID-19 Molecular Diagnostic Tests: Qiagen and Thermofisher Scientific – Africa CDC
![First Syndromic Test Differentiates Between Monkeypox and Five Pathogens with Similar Symptoms - molecular-diagnostics - mobile.Labmedica.com First Syndromic Test Differentiates Between Monkeypox and Five Pathogens with Similar Symptoms - molecular-diagnostics - mobile.Labmedica.com](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2022-08-18/SDD-294794297.jpg)
First Syndromic Test Differentiates Between Monkeypox and Five Pathogens with Similar Symptoms - molecular-diagnostics - mobile.Labmedica.com
![Frontiers | Evaluation of the QIAstat-Dx RP2.0 and the BioFire FilmArray RP2.1 for the Rapid Detection of Respiratory Pathogens Including SARS-CoV-2 Frontiers | Evaluation of the QIAstat-Dx RP2.0 and the BioFire FilmArray RP2.1 for the Rapid Detection of Respiratory Pathogens Including SARS-CoV-2](https://www.frontiersin.org/files/Articles/854209/fmicb-13-854209-HTML/image_m/fmicb-13-854209-t003.jpg)
Frontiers | Evaluation of the QIAstat-Dx RP2.0 and the BioFire FilmArray RP2.1 for the Rapid Detection of Respiratory Pathogens Including SARS-CoV-2
![Drug Discovery News on X: "Receiving FDA 501(k) clearance, QIAGEN launches #QIAstat-Dx syndromic testing & #respiratory panel Respiratory panel detects & identifies >20 #pathogens; company hopes to launch #gastrointestinal panel late 2019 Drug Discovery News on X: "Receiving FDA 501(k) clearance, QIAGEN launches #QIAstat-Dx syndromic testing & #respiratory panel Respiratory panel detects & identifies >20 #pathogens; company hopes to launch #gastrointestinal panel late 2019](https://pbs.twimg.com/media/D7BcXdlW0AAtzvQ.jpg)
Drug Discovery News on X: "Receiving FDA 501(k) clearance, QIAGEN launches #QIAstat-Dx syndromic testing & #respiratory panel Respiratory panel detects & identifies >20 #pathogens; company hopes to launch #gastrointestinal panel late 2019
![Qiagen expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2 - Parc Científic de Barcelona Qiagen expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2 - Parc Científic de Barcelona](https://www.pcb.ub.edu/wp-content/uploads/2021/11/Qiagenweb.jpg)
Qiagen expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2 - Parc Científic de Barcelona
![Frontiers | Evaluation of the QIAstat-Dx RP2.0 and the BioFire FilmArray RP2.1 for the Rapid Detection of Respiratory Pathogens Including SARS-CoV-2 Frontiers | Evaluation of the QIAstat-Dx RP2.0 and the BioFire FilmArray RP2.1 for the Rapid Detection of Respiratory Pathogens Including SARS-CoV-2](https://www.frontiersin.org/files/Articles/854209/fmicb-13-854209-HTML/image_m/fmicb-13-854209-t004.jpg)